Cellectis wins European patent for CRISPR use in T-cells – News-Medical.net
|
Cellectis wins European patent for CRISPR use in T-cells
News-Medical.net "We have been the first to explore the potential of CRISPR in its early days in various applications, including therapeutics and food, and these early findings ultimately led to the grant of this new patent. While Cellectis has selected TALEN® as the … |
